CuraCell TX AB
559280-8546ActiveEuropean biotech developing personalized T-cell therapies for solid cancer tumors.
Overview
- 5
- Employees
- 45K SEK
- Revenue
- 2020
- Founded
Key Decision Makers
Håkan Hallberg
CFO
Lucas Arruda
Chief Scientific Officer
Thomas Schlegel
General Counsel
Jonas Båtelson
CEO
+3 more contacts in Funnelfeedr
Description
CuraCell is a European biotech company focused on developing innovative T-cell therapies for the treatment of solid cancer tumors. The company utilizes its proprietary platform, CytoPLY, designed to significantly expand and activate the patient's own tumor-reactive T-cells. Their primary therapeutic...
Tags
Keywords
Company Information
- Industry
- Bioteknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE559280854601
Decision Makers
7 contacts in FunnelfeedrHåkan Hallberg
CFO
Lucas Arruda
Chief Scientific Officer
Thomas Schlegel
General Counsel
Jonas Båtelson
CEO
Martina Ochel
COO
Per-Henrik Holmqvist
Head of CMC
Torbjörn Ström
Head of Clinical Operations
Similar Companies
20 similar companies in FunnelfeedrUltimovacs AB
0 employeesPioneering off-the-shelf TCR-NK cell therapies to cure solid cancers.
Anocca AB
100–199 employeesEngineering precision T-cell immunotherapies for hard-to-treat cancers.
SeqCure Immunology AB
1 employeesDeveloping personalized, non-genetically engineered cell therapy for advanced cancer.
ZELLUNA ASA
7 employeesPioneering TCR-NK cell therapies to eliminate solid cancers effectively.
ZELLUNA IMMUNOTHERAPY AS
9 employeesPioneering TCR-NK cell therapies to eliminate solid cancers safely.
CuraCell TX AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo